TRCT
XYL icon

Tower Research Capital (TRC)’s Xylem XYL Stock Holding History

Tower Research Capital (TRC)’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$509K Sell
4,259
-486
-10% -$63.7K 0.01% 908
2025
Q4 		$646K Buy
4,745
+2,517
+113% +$362K 0.02% 688
2025
Q3 		$329K Sell
2,228
-8,871
-80% -$1.23M 0.01% 1128
2025
Q2 		$1.44M Buy
11,099
+4,677
+73% +$566K 0.04% 405
2025
Q1 		$767K Sell
6,422
-10,718
-63% -$1.33M 0.02% 616
2024
Q4 		$1.99M Buy
17,140
+5,363
+46% +$678K 0.04% 372
2024
Q3 		$1.59M Buy
11,777
+3
+0% +$401 0.04% 351
2024
Q2 		$1.6M Buy
11,774
+1,243
+12% +$169K 0.03% 524
2024
Q1 		$1.36M Sell
10,531
-25,922
-71% -$3.13M 0.03% 399
2023
Q4 		$4.17M Buy
36,453
+20,133
+123% +$2.01M 0.05% 300
2023
Q3 		$1.49M Buy
16,320
+12,278
+304% +$1.27M 0.05% 397
2023
Q2 		$455K Sell
4,042
-327
-7% -$34.6K 0.02% 1042
2023
Q1 		$458K Buy
4,369
+642
+17% +$67K 0.01% 880
2022
Q4 		$412K Sell
3,727
-11,551
-76% -$1.21M 0.02% 811
2022
Q3 		$1.33M Buy
15,278
+8,081
+112% +$734K 0.02% 578
2022
Q2 		$562K Sell
7,197
-28,587
-80% -$2.36M 0.01% 1070
2022
Q1 		$3.05M Buy
35,784
+20,067
+128% +$1.92M 0.03% 456
2021
Q4 		$1.88M Buy
15,717
+4,796
+44% +$595K 0.03% 431
2021
Q3 		$1.35M Buy
10,921
+7,232
+196% +$931K 0.03% 389
2021
Q2 		$443K Sell
3,689
-12,524
-77% -$1.43M 0.01% 1281
2021
Q1 		$1.71M Buy
16,213
+9,987
+160% +$1.01M 0.03% 540
2020
Q4 		$634K Buy
6,226
+1,882
+43% +$177K 0.02% 821
2020
Q3 		$365K Buy
4,344
+2,390
+122% +$186K ﹤0.01% 2009
2020
Q2 		$127K Buy
+1,954
New +$129K 0.01% 2243
2020
Q1 		– Sell
-63
Closed -$5K – 4023
2019
Q4 		$5K Sell
63
-4,420
-99% -$344K ﹤0.01% 2718
2019
Q3 		$357K Buy
4,483
+4,440
+10,326% +$349K 0.02% 724
2019
Q2 		$4K Sell
43
-3,694
-99% -$294K ﹤0.01% 3069
2019
Q1 		$295K Buy
3,737
+1,252
+50% +$91.4K 0.02% 947
2018
Q4 		$166K Buy
2,485
+1,246
+101% +$86.2K 0.01% 757
2018
Q3 		$99K Buy
+1,239
New +$92.5K 0.01% 1356
2018
Q2 		– Sell
-900
Closed -$69K – 4114
2018
Q1 		$69K Buy
+900
New +$66.5K 0.01% 1504
2017
Q4 		– Sell
-103
Closed -$6K – 4085
2017
Q3 		$6K Sell
103
-2,921
-97% -$175K ﹤0.01% 3270
2017
Q2 		$168K Buy
+3,024
New +$157K 0.02% 377
2017
Q1 		– Sell
-6,712
Closed -$327K – 4023
2016
Q4 		$333K Buy
6,712
+4,536
+208% +$230K 0.04% 467
2016
Q3 		$114K Sell
2,176
-3,044
-58% -$149K 0.01% 748
2016
Q2 		$233K Buy
+5,220
New +$227K 0.02% 574
2016
Q1 		– Sell
-597
Closed -$22K – 5051
2015
Q4 		$22K Buy
597
+497
+497% +$18K ﹤0.01% 1217
2015
Q3 		$3K Buy
+100
New +$3.37K ﹤0.01% 3185
2015
Q2 		– Sell
-1,844
Closed -$65K – 5123
2015
Q1 		$65K Buy
1,844
+1,785
+3,025% +$63K 0.01% 1258
2014
Q4 		$2K Sell
59
-937
-94% -$34.3K ﹤0.01% 3402
2014
Q3 		$35K Buy
+996
New +$37K ﹤0.01% 1838
2014
Q2 		– Sell
-3,099
Closed -$112K – 4717
2014
Q1 		$112K Sell
3,099
-4,728
-60% -$172K 0.01% 647
2013
Q4 		$271K Buy
7,827
+6,131
+361% +$197K 0.05% 380
2013
Q3 		$47K Buy
+1,696
New +$45.2K 0.01% 1968

Other funds holding XYL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Tower Research Capital (TRC)'s XYL Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Xylem (XYL) stake by 10% in Q1 2026, selling an estimated $63.7K and leaving 4,259 shares worth $509K. The position accounts for 0.01% of the portfolio, ranked #908.

Tower Research Capital (TRC) first reported a position in XYL in Q3 2013 and has held it in 44 quarters since. The position peaked at $4.17M in Q4 2023. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Tower Research Capital (TRC) held 4,259 shares of Xylem worth $509K as of Q1 2026.
  • Tower Research Capital (TRC) sold 486 Xylem shares in Q1 2026, an estimated $63.7K.
  • Xylem made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #908 holding.
  • Tower Research Capital (TRC) first reported a position in Xylem in Q3 2013 and has held it in 44 quarters since.
  • Tower Research Capital (TRC)'s Xylem position peaked at $4.17M in Q4 2023.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.